Dr. Deepa Panjeti-Moore, DO

Dr. Panjeti-Moore practices at INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health.

Dr. Panjeti-Moore's NPI, 1699185439, was assigned on May 1, 2014. Dr. Panjeti-Moore graduated from PCOM Georgia - Suwanee in 2014. Dr. Panjeti-Moore holds Texas license S7526.

Dr. Panjeti-Moore's primary practice is INTEGRIS Health Baptist Medical Center, at 3300 Northwest Expressway, Oklahoma City, OK 73112 in Oklahoma County. The practice phone is (405) 949-3011.

Dr. Panjeti-Moore's primary practice is INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health. The medical group on file is INTEGRIS Health Medical Group. Dmand AI also links Dr. Panjeti-Moore to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panjeti-Moore practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Panjeti-Moore's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Panjeti-Moore is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Panjeti-Moore is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, head injury, lower back pain and migraine and chronic headache among the conditions Dr. Panjeti-Moore treats.

CMS data shows 1,283 Medicare services from Dr. Panjeti-Moore across 20 procedure codes in 2024, for 357 Medicare patients. Medicare paid $128,001 for them.

CMS counts 357 Medicare patients who saw Dr. Panjeti-Moore in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Panjeti-Moore's median patient age at 64, with 53% women.

In 2024, Dr. Panjeti-Moore wrote 333 Medicare Part D claims for 99 patients. 80% of them were for generic drugs. CMS names the drug for 199 of them, across 10 drugs with 11 or more claims each, at $15,563 in total drug cost. In 2023, CMS named 569 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Panjeti-Moore for performance year 2024, reported as part of a group. Dr. Panjeti-Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Panjeti-Moore, published from 2023 to 2024. 2023 was the busiest year, with 2. Dr. Panjeti-Moore has published most often in Epilepsy Behav. Dr. Panjeti-Moore's most frequent co-authors are Danielle Alyse Becker, MD, Selim Ramin Benbadis, MD and Leonardo Fator Gouvea Bonilha, MD, PhD.

CMS Open Payments shows 366 general payments to Dr. Panjeti-Moore from 45 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 30% of the total. Neurelis, Inc. paid the most, $22,238.

Dr. Panjeti-Moore graduated from PCOM Georgia - Suwanee in 2014. Dr. Panjeti-Moore is a member of AAN, AES and AOA.

Dr. Panjeti-Moore is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.